Olfactory Ensheathing Cells in Parkinson's Disease

Olfactory Ensheathing Cells in Parkinson's Disease

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Olfactory Ensheathing Cells in Parkinson's Disease</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0011028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0011028)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0011028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0011028)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4301615](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4301615)</td>
</tr>
<tr>
<td class="label">Gene/Protein</td>
<td>Function in OECs</td>
</tr>
<tr>
<td class="label">SNCA</td>
<td>Alpha-synuclein aggregation</td>
</tr>
<tr>
<td class="label">PINK1</td>
<td>Mitochondrial quality control</td>
</tr>
<tr>
<td class="label">PARK2</td>
<td>Ubiquitin-proteasome system</td>
</tr>
<tr>
<td class="label">GBA</td>
<td>Lysosomal function</td>
</tr>
<tr>
<td class="label">BDNF</td>
<td>Neurotrophic support</td>
</tr>
<tr>
<td class="label">GDNF</td>
<td>Dopaminergic protection</td>
</tr>
<tr>
<td class="label">TNF</td>
<td>Pro-inflammatory

Olfactory Ensheathing Cells in Parkinson's Disease

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Olfactory Ensheathing Cells in Parkinson's Disease</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0011028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0011028)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0011028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0011028)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4301615](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4301615)</td>
</tr>
<tr>
<td class="label">Gene/Protein</td>
<td>Function in OECs</td>
</tr>
<tr>
<td class="label">SNCA</td>
<td>Alpha-synuclein aggregation</td>
</tr>
<tr>
<td class="label">PINK1</td>
<td>Mitochondrial quality control</td>
</tr>
<tr>
<td class="label">PARK2</td>
<td>Ubiquitin-proteasome system</td>
</tr>
<tr>
<td class="label">GBA</td>
<td>Lysosomal function</td>
</tr>
<tr>
<td class="label">BDNF</td>
<td>Neurotrophic support</td>
</tr>
<tr>
<td class="label">GDNF</td>
<td>Dopaminergic protection</td>
</tr>
<tr>
<td class="label">TNF</td>
<td>Pro-inflammatory cytokine</td>
</tr>
<tr>
<td class="label">IL1B</td>
<td>Inflammatory mediator</td>
</tr>
<tr>
<td class="label">TGF-beta</td>
<td>Immunomodulation</td>
</tr>
<tr>
<td class="label">NGF</td>
<td>Neuronal differentiation</td>
</tr>
</table>

Olfactory Ensheathing Cells In Parkinson'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.

Overview

Olfactory ensheathing cells (OECs) are specialized glial cells in the olfactory system that guide olfactory neuron regeneration. Their dysfunction may contribute to olfactory impairment in Parkinson's disease and represent potential therapeutic targets. [@doucette1995]

<!-- taxonomy-enrichment --> [@feron2001]

<!-- multi-taxonomy-enrichment --> [@garciaescudero2012]

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

• [Cell Ontology (CL:0011028)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0011028)
• [OBO Foundry (CL:0011028)](http://purl.obolibrary.org/obo/CL_0011028)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Taxonomy & Classification

External Database Links

• [Cell Ontology (CL:0011028)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0011028)
• [OBO Foundry (CL:0011028)](http://purl.obolibrary.org/obo/CL_0011028)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)

OEC Function

Normal Physiology

• Axon guidance for olfactory receptor neurons
• Myelin formation in olfactory nerve
• Olfactory bulb support cells
• Regeneration support capacity

Unique Properties

• Hybrid astrocyte-Schwann cell phenotype
• Continuous regeneration support
• Blood-nerve barrier maintenance

Involvement in PD

Dysfunction Mechanisms

• Alpha-synuclein accumulation
• Impaired phagocytosis
• Reduced regenerative capacity
• Inflammatory response alterations

Clinical Relevance

• Olfactory restoration potential
• Therapeutic target for hyposmia
• Cell transplantation candidate

Therapeutic Potential

Transplantation Studies

• OEC transplantation in PD models
• Functional recovery reports
• Dopaminergic neuron survival enhancement

Challenges

• Limited availability
• Variable efficacy
• Optimal delivery methods

Molecular Mechanisms

Olfactory ensheathing cells (OECs) are implicated in Parkinson's disease through several molecular pathways:

Alpha-Synuclein Pathology

• OECs can phagocytose alpha-synuclein aggregates but show impaired clearance in PD
• Accumulation of alpha-synuclein in OECs contributes to olfactory dysfunction
• Lewy body-like inclusions found in olfactory mucosa OECs of PD patients

Neuroinflammation

• OECs produce pro-inflammatory cytokines including TNF, IL1B, and IL6
• Chronic neuroinflammation reduces OEC regenerative capacity
• Altered TGF-beta signaling in PD OECs

Mitochondrial Dysfunction

• Impaired mitochondrial function in PD OECs
• Reduced PINK1 and PARK2 expression affects OEC survival
• Oxidative stress sensitivity in olfactory ensheathing cells

Neurotrophic Factor Signaling

• Reduced BDNF secretion in PD OECs
• Impaired GDNF signaling affects dopaminergic neuron support
• Altered NTRK2 receptor expression

Key Genes and Proteins

Signaling Pathways

Pathways Active in OECs

• Neuroinflammation signaling — chronic activation in PD
• Mitochondrial dysfunction pathway — energy metabolism deficits
• Oxidative stress response — ROS accumulation
• Alpha-synuclein aggregation pathway — protein aggregation
• Neurotrophic factor signaling — BDNF/GDNF pathways
• Autophagy-lysosomal pathway — protein clearance
• Wnt/beta-catenin signaling — regeneration
• TGF-beta signaling — immunomodulation

Disease Associations

Primary Disease

• Parkinson's Disease — primary disease of interest
• Idiopathic Parkinson's Disease — sporadic PD
• LRRK2-associated Parkinson's Disease — genetic PD form

Related Neurodegenerative Diseases

• Dementia with Lewy Bodies — alpha-synuclein pathology
• Multiple System Atrophy — oligodendroglial pathology
• Progressive Supranuclear Palsy — tau pathology
• Alzheimer's Disease — olfactory dysfunction

Related Conditions

• Hyposmia — olfactory loss in PD
• Anosmia — complete smell loss
• REM Sleep Behavior Disorder — PD prodrome

Therapeutic Implications

Disease-Modifying Approaches

• OEC transplantation to replace damaged olfactory neurons
• Gene therapy to enhance GDNF/BDNF expression in OECs
• Cell-based delivery of therapeutic proteins to brain regions
• Combination approaches with neurotrophic factors

Neuroprotective Strategies

• Anti-inflammatory agents to modulate OEC function
• Antioxidant treatment to reduce oxidative stress
• Mitochondrial protectants to improve OEC survival
• Alpha-synuclein clearance via enhanced autophagy

Symptomatic Treatments

• Olfactory training combined with OEC activation
• Smell function restoration through OEC regeneration
• Neurotrophic factor delivery for dopaminergic protection

Emerging Therapies

• iPSC-derived OECs for autologous transplantation
• Bioengineered OEC scaffolds for targeted delivery
• CRISPR-based gene editing to correct PD mutations
• Exosome therapy from engineered OECs

Background

The study of Olfactory Ensheathing Cells In Parkinson'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [/mechanisms/alpha-synuclein](/mechanisms/alpha-synuclein-aggregation-pathway)
• /diseases
• /mechanisms
• /all-pages

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Cross-References

• [Olfactory Ensheathing Cells](/cell-types/olfactory-ensheathing-cells)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Hyposmia in Parkinson's Disease](/symptoms/hyposmia-parkinsons)
• [Olfactory System](/brain-regions/olfactory-system)
• [Glial Cells](/cell-types/radial-glial-cells)
• [Cell Therapy for Parkinson's Disease](/proteins/parkin)

Pathway Diagram

The following diagram shows the key molecular relationships involving Olfactory Ensheathing Cells in Parkinson's Disease discovered through SciDEX knowledge graph analysis: